10-Q: Verano Holdings Corp. Reports Q3 2024 Results with Revenue Decline and Increased Net Loss
Quarterly Report
Verano Holdings Corp. experienced a decrease in revenue and an increase in net loss for the third quarter of 2024, driven by market competition and expansion costs.
Summary
- Verano Holdings Corp. reported a net revenue of $216.7 million for the three months ended September 30, 2024, a decrease of 9.7% compared to the same period in 2023.
- The company's gross profit for the quarter was $109.1 million, with a gross profit margin of 50.3%, down from 55.5% in the prior year.
- Net loss attributable to Verano Holdings Corp. was $42.6 million for the quarter, compared to a net loss of $17.8 million in Q3 2023.
- For the nine months ended September 30, 2024, net revenue was $660.4 million, a decrease of 5.8% compared to the same period in 2023.
- The net loss for the nine-month period was $69.2 million, compared to a net loss of $40.1 million in the prior year.
- The company's working capital deficit was $(113.7) million as of September 30, 2024, a decrease of $(95.7) million compared to December 31, 2023.
- Verano opened eight new stores and acquired eight additional stores during the nine months ended September 30, 2024.
Sentiment
Score: 4
Explanation: The document presents a mixed picture with revenue declines and increased losses, but also highlights expansion efforts. The overall sentiment is negative due to the financial results, but the company's strategic moves and compliance with financial covenants provide some positive aspects.
Positives
- Verano opened eight new stores and acquired eight additional stores during the nine months ended September 30, 2024, expanding its retail footprint.
- The company's cultivation (wholesale) revenue increased by 3.7% for the nine months ended September 30, 2024, driven by third-party sales in New Jersey and Maryland.
- The company is in compliance with the financial covenants of its 2022 Credit Agreement.
Negatives
- Verano experienced a decrease in revenue of 9.7% in Q3 2024 compared to Q3 2023.
- The company's gross profit margin decreased to 50.3% in Q3 2024 from 55.5% in Q3 2023.
- Net loss increased to $42.6 million in Q3 2024, compared to $17.8 million in Q3 2023.
- The company's working capital deficit was $(113.7) million as of September 30, 2024.
- The company experienced price compression in Arizona, Florida, Illinois and New Jersey due to increased competition.
Risks
- The company faces increased competition and promotional activity in key retail markets like New Jersey and Illinois.
- The company's operations are subject to the risks associated with the illegality of cannabis under U.S. federal law.
- The company's financial performance is affected by price compression and promotional activity in select retail markets.
- The company's expansion strategy and revenue growth may put pressure on margins in the cultivation (wholesale) and retail channels.
- The company's ability to fund its operating needs depends on its ability to generate positive cash flow and obtain financing on acceptable terms.
Future Outlook
The company expects to continue its expansion strategy, exploring new markets and opening or acquiring new dispensary locations. The company anticipates pressure on margins in the cultivation (wholesale) and retail channels as state markets mature. The company expects price compression at the cultivation (wholesale) level to be offset by operational optimization.
Management Comments
- Management believes that internally generated funds and other sources of liquidity will be sufficient to meet working capital needs, capital expenditures, payments of income tax payables and other business requirements for at least the next 12 months.
- Management takes a cautious approach in allocating its capital to maximize its returns while ensuring appropriate liquidity.
Industry Context
The results reflect the challenges faced by multi-state cannabis operators, including increased competition, price compression, and the need for continued investment in expansion. The company's performance is also affected by the regulatory landscape and the ongoing illegality of cannabis under U.S. federal law.
Comparison to Industry Standards
- The decrease in revenue and gross profit margin is consistent with trends seen in other multi-state cannabis operators facing increased competition in mature markets like Illinois and New Jersey.
- The company's expansion strategy, while contributing to revenue growth in some areas, also results in increased operating expenses, which is a common challenge for companies in the growth phase.
- The company's working capital deficit is a concern, but it is not uncommon for companies in the cannabis industry to have negative working capital due to the capital-intensive nature of the business and the challenges in accessing traditional financing.
- The company's performance is comparable to other cannabis companies that are experiencing similar challenges in the current market environment.
Legal Proceedings
- The company is engaged in ongoing litigation with Goodness Growth Holdings, Inc. regarding a terminated arrangement agreement.
- Goodness Growth Holdings, Inc. is seeking $860,900 in damages, plus costs and interest.
Related Party Transactions
- George Archos, the Chairman, Chief Executive Officer and Founder of the Company, participated in the 2022 Credit Agreement as a Lender.
- The company leases real property for retail dispensaries from entities in which George Archos holds an indirect ownership interest.
- The company uses point of sale software systems from Sweed, an entity in which George Archos holds an indirect ownership interest.
Stakeholder Impact
- Shareholders may be concerned about the decrease in revenue and increase in net loss.
- Employees may be affected by the company's cost-cutting measures and changes in operations.
- Customers may experience changes in product availability and pricing due to market competition and expansion efforts.
- Suppliers may be affected by the company's changes in purchasing and inventory management.
- Creditors may be concerned about the company's working capital deficit and ability to repay its debts.
Next Steps
- The company will continue to monitor and deploy its capital to minimize the negative impact on its operations and expansion plans.
- The company will continue to focus on operational optimization to offset price compression at the cultivation (wholesale) level.
- The company will continue to expand its retail footprint through new store openings and acquisitions.
Key Dates
| Date | Description |
|---|---|
| July 29, 2024 | Date of equity purchase agreements for acquisitions in Arizona and Virginia. |
| August 16, 2024 | Closing date for the acquisition of 203 Organix L.L.C. and Salubrious Wellness Clinic, Inc. |
| August 21, 2024 | Closing date for the acquisition of Columbia Care Eastern Virginia LLC. |
| September 9, 2024 | Date that Laura Marie Kalesnik adopted a prearranged share trading plan. |
| September 30, 2024 | End of the reporting period for the quarterly results. |
| October 28, 2024 | Date of amendment to the equity purchase agreement with 203 Organix L.L.C. |
| November 5, 2024 | Date of share count and operational update. |
| November 7, 2024 | Date of filing of the quarterly report. |
Keywords
cannabis, marijuana, retail, cultivation, wholesale, revenue, net loss, gross profit, financial results, multi-state operator, expansion, competition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.